Home
>
National Drug Code (NDC)
>
Lithostat
Lithostat - 0178-0500-01 - (acetohydroxamic acid)
Drug Information of Lithostat
| Product NDC: | 0178-0500 |
| Proprietary Name: | Lithostat |
| Non Proprietary Name: | acetohydroxamic acid |
| Active Ingredient(s): | 250 mg/1 & nbsp; acetohydroxamic acid |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Lithostat
| Product NDC: | 0178-0500 |
| Labeler Name: | Mission Pharmacal Company |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA018749 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19830531 |
Package Information of Lithostat
| Package NDC: | 0178-0500-01 |
| Package Description: | 100 TABLET in 1 BOTTLE (0178-0500-01) |
NDC Information of Lithostat
| NDC Code | 0178-0500-01 |
| Proprietary Name | Lithostat |
| Package Description | 100 TABLET in 1 BOTTLE (0178-0500-01) |
| Product NDC | 0178-0500 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | acetohydroxamic acid |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19830531 |
| Marketing Category Name | NDA |
| Labeler Name | Mission Pharmacal Company |
| Substance Name | ACETOHYDROXAMIC ACID |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Urease Inhibitor [EPC],Urease Inhibitors [MoA] |
